Evogene
EVGN
EVGN
14 hedge funds and large institutions have $1.7M invested in Evogene in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
82% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 17
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$598K | |
| 2 | +$30.7K | |
| 3 | +$6.63K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$6.14K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$890 |
Top Sellers
| 1 | -$43.8K | |
| 2 | -$39.9K | |
| 3 | -$38.4K | |
| 4 |
Renaissance Technologies
New York
|
-$29.1K |
| 5 |
Morgan Stanley
New York
|
-$28.4K |